LETTER
Novel Synthesis of Bicyclo[3.3.0]octane Ring System
1585
of diastereomers and their enols. IR (film): 2937, 2858,
1755, 1726, 1657, 1446, 1398, 1352, 1230, 1161, 1005, 852
cm–1. 1H NMR (400 MHz, CDCl3): d = 10.3 (br, 0.2 H), 10.2
(br, 0.04 H), 7.48–7.32 (m, 5 H), 6.42 (s, 0.4 H), 6.24 (s, 0.6
H), 5.77–5.59 (m, 2 H), 3.83–3.13 (m, 7 H), 2.78–2.68 (m, 2
H), 2.22–2.05 (m, 2 H), 1.44–1.27 (m, 5 H), 1.06–1.04 (m, 1
H). 13C NMR (100 MHz, CDCl3): d = 216.3, 169.3, 166.8,
166.6, 165.8, 164.0, 135.0, 134.2, 132.8, 131.7, 129.6,
129.4, 129.3, 128.7, 128.6, 128.5, 127.7, 103.1, 75.4, 74.6,
73.0, 59.6, 59.0, 53.3, 51.7, 46.7, 45.3, 43.9, 41.1, 40.6, 40.3,
36.4, 34.7. HRMS (FAB): m/z calcd for C22H26NO4 [MH+]:
368.1861; found: 368.1858 [MH+].
O
O
O
Rh catalyst
(10 mol%)
OAllyl
O
OAllyl
H
N2
CH2Cl2
H
14
Yield (%) ee (%)
13
Rh catalyst
Rh2(S-DOSP)4
Rh2(S-PTTL)4
Rh2(S-PTPA)4
30
16
58
43
11
4
Scheme 3
Compounds 15a and 15b: to a solution of 5d (8.9 mg, 0.023
mmol) in THF (0.3 mL) was added NaHMDS in THF (34
mL, 0.034 mmol, 1.5 equiv) at 0 °C. After stirring for 30 min
at the same temperature, BOMCl (5.0 mL, 0.035 mmol, 1.5
equiv) was added. After stirring for 30 min, the reaction
mixture was quenched by sat. aq NH4Cl, extracted with
EtOAc. The organic layer was washed with brine, dried over
MgSO4, and concentrated under reduced pressure. The
residue was purified by preparative TLC (50% EtOAc in
hexane) to afford 15a (4.9 mg, 0.010 mmol, 44 %) as a
colorless oil and its isomer 15b (0.6 mg, 0.0012 mmol, 5%)
as a colorless oil.
O
BOM
OR
NaHMDS
BOMCl
H
5
THF
O
H
15
Scheme 4
Analytical Data for Compound 15a.
O
[a]D21 +94.2 (c 0.165, CHCl3). IR (neat film): 2937, 2856,
1708, 1657, 1450, 1378, 1217, 1144, 1016 cm–1. 1H NMR
(400 MHz, CDCl3): d = 7.50–7.28 (m, 10 H), 6.41 (s, 1 H),
5.79 (dd, J = 5.6, 2.3 Hz, 1 H), 5.58 (dd, J = 5.6, 2.0 Hz, 1
H), 5.15 (d, J = 4.3 Hz, 2 H), 4.66 (s, 2 H), 4.07 (dd, J = 8.2,
2.0 Hz, 1 H), 3.62 (m, 1 H), 3.49–3.41 (m, 3 H), 3.03 (dd,
J = 18.0, 9.9 Hz, 1 H), 2.91 (m, 1 H), 2.68 (m, 1 H), 2.45
(ddd, J = 17.4, 4.7, 2.1 Hz, 1 H), 2.10 (m, 1 H) 1.54–1.45 (m,
5 H), 1.16 (m, 1 H), 13C NMR (700 MHz, CDCl3): d = 167.8,
166.8, 164.0, 146.0, 140.9, 137.2, 135.7, 133.5, 129.2,
129.0, 128.9, 128.6, 128.5, 128.3, 128.2, 127.7, 109.1, 92.8,
72.7, 71.9, 54.5, 43.8, 42.3, 40.8, 39.2, 34.7, 29.7, 25.7, 24.7,
24.2. HRMS–FAB: m/z calcd for C30H34NO5 [MH+]:
488.2437; found: 488.2445 [MH+].
H
1) allyl alcohol, DMAP, toluene
2) pyrrolidine, Pd(PPh3)4, MeCN
5
H
16
Scheme 5
(12) The absolute configuration of 5 was determined as 2R,3R by
comparing the optical rotation with that of reported
compound 16, see ref. 13. Preparation of 16 from 5 was
performed by a decarbonylation reaction (Scheme 5).
(13) Kashihara, H.; Suemune, H.; Kawahara, T.; Sakai, K.
Tetrahedron Lett. 1987, 28, 6489.
Analytical Data for Compound 15b.
(14) Watanabe, N.; Ogawa, T.; Ohtake, Y.; Ikegami, S.;
Hashimoto, S. Synlett 1996, 85.
[a]D22 +15.3 (c 0.090, CHCl3). IR (neat film): 2935, 1709,
1654, 1454, 1215, 1018 cm–1. 1H NMR (400 MHz, CDCl3):
d = 7.52–7.28 (m, 10 H), 6.42 (s, 1 H), 6.18 (dd, J = 5.7, 2.3
Hz, 1 H), 5.66 (dd, J = 5.7, 2.1 Hz, 1 H), 5.12 (s, 2 H), 4.65
(s, 2 H), 3.98 (dd, J = 8.2, 2.0 Hz, 1 H), 3.61–3.39 (m, 4 H),
3.03 (dd, J = 18.3, 9.8 Hz, 1 H), 2.88 (m, 1 H), 2.67 (m, 1 H),
2.50 (m, 1 H), 2.10 (m, 1 H), 1.54–1.45 (m, 5 H), 1.16 (m, 1
H), 13C NMR (100 MHz, CDCl3): d = 167.3, 166.7, 163.7,
157.1, 136.9, 135.5, 133.3, 128.8, 128.7, 128.4, 128.2,
128.1, 111.3, 92.6, 72.2, 70.3, 54.4, 46.3, 43.3, 40.6, 39.0,
34.3, 25.4, 24.5, 24.0. HRMS–FAB: m/z calcd for
C30H34NO5 [MH+]: 488.2437; found: 488.2428 [MH+].
(19) (a) For a pentalenolactone, see: Mori, K.; Tsuji, M.
Tetrahedron 1988, 44, 2835. (b) For a jasmonic acid
analogue, see: Toshima, H.; Nara, S.; Fujino, Y.; Ichihara,
A. Bioscience, Biotechnology, and Biochemistry 2000, 64,
2702.
(15) (a) Watanabe, N.; Ogawa, T.; Ohtake, Y.; Ikegami, S.;
Hashimoto, S. Synlett 1996, 85. (b) Hashimoto, S.;
Watanabe, N.; Ikegami, S. Tetrahedron Lett. 1990, 31, 5173.
(16) A similar interaction was observed in Rh carbenoid
mediated intermolecular cyclopropanation, see: Davies, H.
M. L.; Huby, N. J. S.; Cantrell, W. R. Jr.; Olive, J. L. J. Am.
Chem. Soc. 1993, 115, 9468.
(17) The C–H insertion 4d reaction with Rh2(OAc)4 proceeded
smoothly to afford 5a in 94% yield and a 43% de.
(18) Experimental procedure for the C–H insertion reaction of
diazoester 4d and confirmation of the diastereoselectivity by
conversion of 13a and 13b from 5d are described below.
Compound 5d: to a solution of diazoester 4d (17.5 mg, 0.044
mmol) in CH2Cl2 (0.4 mL) was added Rh2(S-DOSP)4 (8.4
mg, 0.0044 mmol, 10 mol%) at r.t. After stirring for 5 min at
the same temperature, the reaction mixture was concentrated
under reduced pressure. The residue was purified by
preparative TLC (50% EtOAc in hexane) to afford 5d (8.9
mg, 0.023 mmol, 55%, 78% de) as a yellow oil and mixture
(20) For an isocarbacyclin, see: (a) Hashimoto, S.; Shinoda, T.;
Ikegami, S. Chem. Commun. 1988, 1137. (b) Hashimoto,
S.; Miyazaki, Y.; Ikegami, S. Synlett 1996, 324.
Synlett 2006, No. 10, 1583–1585 © Thieme Stuttgart · New York